A U.S. appeals court on Thursday upheld a lower court ruling that found the formulation patent for AstraZeneca's anti-psychotic drug Seroquel XR was valid and had been infringed by Mylan Inc and other…
(Reuters) - The federal patent court in Germany dealt a blow to AstraZeneca by ruling that a key patent on the anti-psychotic drug Seroquel XR was invalid, the British drugmaker said on Tuesday.
Johnson & Johnson is close to reaching a settlement with the U.S. Justice Department over allegations it promoted anti psychotic drug Risperdal for unapproved uses that could cost the healthcare c…
